SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-10-001542
Filing Date
2010-01-13
Accepted
2010-01-13 16:50:26
Documents
5
Effectiveness Date
2010-01-13

Document Format Files

Seq Description Document Type Size
1 S-8 POS a10-1723_2s8pos.htm S-8 POS 111926
2 EX-5.1 a10-1723_2ex5d1.htm EX-5.1 7068
3 EX-23.1 a10-1723_2ex23d1.htm EX-23.1 3698
4 EX-23.2 a10-1723_2ex23d2.htm EX-23.2 2662
5 EX-23.3 a10-1723_2ex23d3.htm EX-23.3 2642
  Complete submission text file 0001104659-10-001542.txt   129588
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-117602 | Film No.: 10525540
SIC: 2835 In Vitro & In Vivo Diagnostic Substances